Download PDF
Thorac Cardiovasc Surg 2021; 69(02): 133-140
DOI: 10.1055/s-0040-1708472
Original Cardiovascular

Perioperative Beta-Blocker for Atrial Fibrillation after Cardiac Surgery: A Meta-Analysis

Sue Hyun Kim
1   Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, the Republic of Korea
,
Myoung-jin Jang
2   Medical Research Collaborating Center, Seoul National University Hospital, Seoul, the Republic of Korea
,
Ho Young Hwang
1   Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, the Republic of Korea
› Author Affiliations
› Further Information
    Permissions and Reprints All articles of this category

Abstract

Background This meta-analysis was conducted to evaluate the impact of perioperative use of beta-blocker (BB) on postoperative atrial fibrillation (POAF) after cardiac surgery other than isolated coronary artery bypass grafting (CABG).

Methods Five online databases were searched. Studies were included if they (1) enrolled patients who underwent cardiac surgery other than isolated CABG and (2) demonstrated the impact of perioperative use of BB on POAF based on the randomized controlled trial or adjusted analysis. The primary outcome was the occurrence rates of POAF after cardiac surgery. A meta-regression and subgroup analysis were performed according to the proportion of patients with cardiac surgery other than isolated CABG and the timing of BB use, respectively.

Results Thirteen articles (5 randomized and 8 nonrandomized studies: n = 25,496) were selected. Proportion of enrolled patients undergoing cardiac surgery other than isolated CABG ranged from 7 to 100%. The BBs were used in preoperative, postoperative, and both periods in 5, 5, and 3 studies, respectively. The pooled analyses showed that the risk of POAF was significantly lower in patients with perioperative BB than those without (odds ratio, 95% confidence interval = 0.56, 0.35–0.91 and 0.70, 0.55–0.91 in randomized and nonrandomized studies, respectively). The risk of POAF was lower in the BB group irrespective of the proportion of nonisolated CABG. Benefit regarding in-hospital mortality was inconclusive. Perioperative stroke and length of stay were not significantly different between BB and non-BB groups.

Conclusions Perioperative use of BB is effective in preventing POAF even in patients undergoing cardiac surgery other than isolated CABG, although it did not translate into improved clinical outcomes.

Keywords

statistics - surgery - complications - cardiac

Supplementary Material



Publication History

Received: 08 November 2019

Accepted: 13 January 2020

Article published online:
06 April 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Almassi GH, Pecsi SA, Collins JF, Shroyer AL, Zenati MA, Grover FL. Predictors and impact of postoperative atrial fibrillation on patients' outcomes: a report from the randomized on versus off bypass trial. J Thorac Cardiovasc Surg 2012; 143 (01) 93-102
    CrossrefPubMedSearch in Google Scholar
  • 2 Kaw R, Hernandez AV, Masood I, Gillinov AM, Saliba W, Blackstone EH. Short- and long-term mortality associated with new-onset atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2011; 141 (05) 1305-1312
    CrossrefPubMedSearch in Google Scholar
  • 3 Kirchhof P, Benussi S, Kotecha D. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 2016; 50 (05) e1-e88
    CrossrefPubMedSearch in Google Scholar
  • 4 Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002; 106 (01) 75-80
    CrossrefPubMedSearch in Google Scholar
  • 5 Hillis LD, Smith PK, Anderson JL. et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124 (23) e652-e735
    PubMedSearch in Google Scholar
  • 6 Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. ; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8 (05) 336-341
    CrossrefPubMedSearch in Google Scholar
  • 7 Sterne JA, Hernán MA, Reeves BC. et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919
    Search in Google Scholar
  • 8 Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014; 14: 135
    CrossrefPubMedSearch in Google Scholar
  • 9 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327 (7414): 557-560
    CrossrefPubMedSearch in Google Scholar
  • 10 Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat 1950; 21: 607-611
    CrossrefPubMedSearch in Google Scholar
  • 11 Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56 (02) 455-463
    CrossrefPubMedSearch in Google Scholar
  • 12 Connolly SJ, Cybulsky I, Lamy A. et al; Beta-Blocker Length Of Stay (BLOS) study. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study. Am Heart J 2003; 145 (02) 226-232
    CrossrefPubMedSearch in Google Scholar
  • 13 Auer J, Weber T, Berent R. et al; Study of Prevention of Postoperative Atrial Fibrillation. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Am Heart J 2004; 147 (04) 636-643
    CrossrefPubMedSearch in Google Scholar
  • 14 Coleman CI, Perkerson KA, Gillespie EL. et al. Impact of prophylactic postoperative beta-blockade on post-cardiothoracic surgery length of stay and atrial fibrillation. Ann Pharmacother 2004; 38 (12) 2012-2016
    CrossrefPubMedSearch in Google Scholar
  • 15 Workman AJ, Pau D, Redpath CJ. et al. Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology. J Cardiovasc Electrophysiol 2006; 17 (11) 1230-1238
    CrossrefPubMedSearch in Google Scholar
  • 16 Shirzad M, Karimi A, Tazik M. et al. Determinants of postoperative atrial fibrillation and associated resource utilization in cardiac surgery. Rev Esp Cardiol 2010; 63 (09) 1054-1060
    CrossrefPubMedSearch in Google Scholar
  • 17 Silva RG, Lima GG, Guerra N, Bigolin AV, Petersen LC. Risk index proposal to predict atrial fibrillation after cardiac surgery. Rev Bras Cir Cardiovasc 2010; 25 (02) 183-189
    CrossrefPubMedSearch in Google Scholar
  • 18 Sakaguchi M, Sasaki Y, Hirai H. et al. Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery. Int Heart J 2012; 53 (06) 359-363
    CrossrefPubMedSearch in Google Scholar
  • 19 Skiba MA, Pick AW, Chaudhuri K. et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung Circ 2013; 22 (08) 627-633
    CrossrefPubMedSearch in Google Scholar
  • 20 Cheng N, Gao C. Prophylactic effects of metoprolol on the prevention of atrial fibrillation after cardiac surgery are dose dependent. Heart Surg Forum 2014; 17 (01) E54-E60
    CrossrefPubMedSearch in Google Scholar
  • 21 Toppen W, Sareh S, Satou N. et al. Do preoperative β-blockers improve postoperative outcomes in patients undergoing cardiac surgery? Challenging societal guidelines. Am Surg 2014; 80 (10) 1018-1021
    CrossrefPubMedSearch in Google Scholar
  • 22 Sezai A, Osaka S, Yaoita H. et al. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial. J Thorac Cardiovasc Surg 2015; 150 (04) 957-964
    CrossrefPubMedSearch in Google Scholar
  • 23 O'Neal JB, Billings IV FT, Liu X. et al. Effect of preoperative beta-blocker use on outcomes following cardiac surgery. Am J Cardiol 2017; 120 (08) 1293-1297
    CrossrefPubMedSearch in Google Scholar
  • 24 Yokota J, Nishi H, Sekiya N, Yamada M, Takahashi T. Atrial fibrillation following aortic valve replacement: impact of perioperative use of intravenous β-blocker. Gen Thorac Cardiovasc Surg 2017; 65 (04) 194-199
    CrossrefPubMedSearch in Google Scholar
  • 25 Echahidi N, Pibarot P, O'Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008; 51 (08) 793-801
    CrossrefPubMedSearch in Google Scholar
  • 26 January CT, Wann LS, Alpert JS. et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64 (21) e1-e76
    CrossrefPubMedSearch in Google Scholar
  • 27 Mathew JP, Parks R, Savino JS. et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA 1996; 276 (04) 300-306
    CrossrefPubMedSearch in Google Scholar
  • 28 Wyse DG, Waldo AL, DiMarco JP. et al; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347 (23) 1825-1833
    CrossrefPubMedSearch in Google Scholar
  • 29 Aranki SF, Shaw DP, Adams DH. et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996; 94 (03) 390-397
    CrossrefPubMedSearch in Google Scholar
  • 30 Crystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev 2004; 4 (04) CD003611
    PubMedSearch in Google Scholar
  • 31 Blessberger H, Kammler J, Domanovits H. et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity. Cochrane Database Syst Rev 2018; 3: CD004476
    PubMedSearch in Google Scholar
  • 32 Sousa-Uva M, Head SJ, Milojevic M. et al. 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg 2018; 53 (01) 5-33
    CrossrefPubMedSearch in Google Scholar